Angus Chen

In this discussion, Angus Chen, a cancer reporter for STAT News, uncovers the implications of proposed cuts to the National Cancer Institute under the Trump administration. He highlights alarming impacts on funding, with potential threats to jobs and clinical trials. Chen emphasizes advancements like Tigrisso for lung cancer, showcasing how collaborative funding drives success. He also addresses challenges in federal grant processes and the urgent need to retain medical talent amid funding declines. The conversation raises critical concerns about the future of cancer research.

Angus Chen, a cancer reporter for Stat News, joins oncologist Dr. Adil Daud from UCSF to discuss alarming federal budget cuts affecting cancer research. They explore how slashes to the NIH budget threaten decades of progress in treatment and patient care. Personal anecdotes illustrate the emotional turmoil faced by patients relying on clinical trials, as well as the impact on crucial research initiatives for high-mortality cancers. The conversation emphasizes the need for continued advocacy and funding to sustain vital advancements in cancer treatment.